Loading…
5 companies · GEL, thousands · columns ordered by revenue
Only 4 of 5 peers filed FY2024. Switch to FY2023 (5 of 5).
| Line item | Eliavas Saertashoriso P… | Deamedi | Davit Tatishvilis Samed… | Diakori | Ekim Bubnovskis Tsentri |
|---|---|---|---|---|---|
| Total Revenue | 3,457 | 3,423 | 3,302 | 3,268 | — |
| Total COGS | -1,160 | -417 | 0 | -493 | — |
| Gross Profit | 2,297 | 3,006 | 3,302 | 2,775 | — |
| Gross Margin | 66.4% | 87.8% | 100.0% | 84.9% | — |
| Total Operating Expenses | -1,163 | -2,028 | -2,853 | -2,194 | — |
| EBITDA | 1,134 | 978 | 449 | 581 | — |
| EBITDA Margin | 32.8% | 28.6% | 13.6% | 17.8% | — |
| Total D&A | -26 | -51 | -85 | -74 | — |
| EBIT / Operating Income | 1,108 | 927 | 364 | 508 | — |
| Total Other Income | -39 | 18 | -0 | 316 | — |
| Profit Before Tax | 1,069 | 921 | 400 | 796 | — |
| Total Income Tax | -109 | -104 | 0 | -43 | — |
| Net Profit / (Loss) | 960 | 818 | 400 | 753 | — |
| Net Margin | 27.8% | 23.9% | 12.1% | 23.1% | — |
| Total Interest Expense | — | -24 | — | -28 | — |
| Total Interest Income | — | — | 36 | — | — |
Not every picked company reports every selected year — FY2024: no filing for Ekim Bubnovskis Tsentri. Those cells are left blank (no filing), not zero.
| Company | Sector | EBITDA margin · FY 2024 | Percentile | Sector n |
|---|---|---|---|---|
| Eliavas Saertashoriso P… | Healthcare Services | 32.8% | 92nd pct | 268 |
| Deamedi | Healthcare Services | 28.6% | 90th pct | 268 |
| Diakori | Healthcare Services | 17.8% | 74th pct | 268 |
| Davit Tatishvilis Samed… | Healthcare Services | 13.6% | 60th pct | 268 |
| Ekim Bubnovskis Tsentri | Healthcare Services | — | no FY data | 268 |
Percentile is within each company's own sector across the whole FY2024 cross-section (1st–100th; higher = larger value). Companies with no sector, or no filing for the year, are not ranked.